Why the study?
Patients with cancer have an increased risk of AMI, but whether the ASCVD risk score at incident AMI reflects this higher risk compared to patients without cancer remains unclear.
Does prior cancer affect the estimated ASCVD risk score at incident AMI and post-AMI mortality compared to patients without prior cancer?
Does prior cancer affect the estimated ASCVD risk score at incident AMI and post-AMI mortality compared to patients without prior cancer?
Patients with prior cancer who develop an incident AMI have lower estimated ASCVD risk scores but experience higher post-AMI mortality and receive less guideline-directed medical therapy compared to those without prior cancer.
May warrant caution applying standard ASCVD scores to prior cancer patients; leaves open need for cancer-specific adjustments.
Background: Patients with cancer are at increased risk of acute myocardial infarction (AMI). It is unclear if the Atherosclerotic Cardiovascular Disease (ASCVD) risk score at incident AMI is reflective of this higher risk in patients with prior cancer than those without. Methods: We linked nationwide AMI and cancer registries from 2008 to 2019. A total of 18,200 eligible patients with ASCVD risk score calculated at incident AMI were identified (1086 prior cancer; 17,114 no cancer). Results: At incident AMI, age-standardized mean ASCVD risk was lower in the prior cancer group (18.6%) than no cancer group (20.9%) (p < 0.001). Prior to incident AMI, smoking, hypertension, hyperlipidemia and diabetes mellitus were better controlled in the prior cancer group. However post-AMI, prior cancer was associated with lower guideline-directed medical therapy usage and higher all-cause mortality (adjusted hazard ratio 1.85, 95% confidence interval 1.66−2.07). Conclusions: AMI occurred despite better control of cardiovascular risk factors and lower age-standardized estimated mean 10-year ASCVD risk among patients with prior cancer than no cancer. Prior cancer was associated with lower guideline-directed medical therapy post-AMI and higher mortality.
No takes yet. Share an insight, caveat, or question.
Koo et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: